PerkinElmer Launches ChemDraw® V21 Software, Empowering Researchers to Rapidly Create Chemically Intelligent Microsoft PowerPoint Reports

Ability to import 3D molecular models with one click accelerates information sharing, collaboration and decision making WALTHAM, Mass. – March 2, 2022 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced V21 of its ChemDraw® software featuring the ability to import, animate and share 3D chemical structures natively in... Read more

PerkinElmer to Present at Upcoming Investor Conferences

WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 1, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen 42nd Annual Health Care Conference and the Barclays Global Healthcare Conference. Cowen 42nd Annual Health Care Conference – Virtual Monday, March 7, 202210:30 a.m. ET –... Read more

Bruker Releases CCS-Enabled TIMScore™ and TIMS DIA-NN 4D Proteomics Software

Bruker PaSER™ 2022 software now features TIMS DIA-NN processing for dia-PASEF® Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies ~9000 protein groups from 200 ng K562 lysate in just 35 min gradient TIMScore further increases phosphopeptides detection by ~25% CHARLESTON, S.C.–(BUSINESS WIRE)– At US HUPO,Bruker Corporation (Nasdaq: BRKR) announced its TIMS... Read more

PacBio Supports SickKids to Investigate Use of HiFi Sequencing in Undiagnosed Genetic Conditions

MENLO PARK, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — PacBio, a leading provider of high-quality, highly accurate sequencing platforms, today announced it will be supporting The Hospital for Sick Children (SickKids) in Toronto, Canada in using HiFi whole genome sequencing (HiFi WGS) to potentially identify genetic variants that may be associated with medical and developmental... Read more

Developing Smarter Steel with Artificial Intelligence Powered Software Analysis

Steel is critical to the future success of our world. As one of the only materials to be completely reusable and recyclable, it will play an essential role in building the circular economy of the future. Steel continues to evolve, becoming smarter and increasingly sustainable. Due to its versatility, steel has undergone enormous technological advances;... Read more

PacBio Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Feb. 25, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 50,000 shares... Read more

TetraScience Announces Collaboration with PerkinElmer to Provide Signals Research™ Suite Customers with Accelerated Time to Value and Improved Scientific Data Outcomes

Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more

PacBio Welcomes Dr. Michael Eberle as Vice President of Computational Biology

MENLO PARK, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, welcomes Michael Eberle, Ph.D., as Vice President of Computational Biology. Michael will be responsible for leading the company’s bioinformatics and data sciences program to enhance PacBio’s genomic analysis offerings. Michael is a genomics industry... Read more

Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration

Agreement to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies CAMBRIDGE, Mass., & WALTHAM, Mass.–(BUSINESS WIRE)– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a 15-year strategic collaboration agreement... Read more